O TYM PODKAŚCIE 🔗
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.
Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.
The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.
Base to Base is an Ayr Coastal Media Ltd production.
Prowadzący:
Częstotliwość aktualizacji:
weekly
Średnia długość dźwięku:
52 minutes
Wywiady gościnne
Język angielski
Stany Zjednoczone
80 odcinków
od 21 marca 2025
episodic
W TYM PODKAŚCIE 🔗
NAJNOWSZY ODCINEK 🔗
This week, we chat with Ryan Beal, a cancer survivor and founder and CEO of Dyve Biosciences, about tumour acidity, and Gene Mack, president and CEO of Gain Therapeutics, about developing allosteric therapies, including taking Parkinson’s disease treatments beyond addressing symptoms.
Times:
03:03 …
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki Base to Base Biotech.
POPRZEDNIE ODCINKI 🔗
This week, we chat with Simon Mølgaard, co-founder and chief executive officer of Teitur Trophics about results from its Parkinson’s disease trial, and have a conversation with Jordi Fàbrega, co-founder and CEO of CONNECTA Therapeutics, and Josep Prous, co-founder and chief scientific officer, abou…
This week, we chat with Lucas Decuypere, CEO and president of Allegro, about treatment of knee osteoarthritis with a nanotechnology injection, and Elin Trampe, the CEO of Dicot Pharma, a company developing a new form of erectile dysfunction treatment.
Times:
01:46 Dicot Pharma
17:21 Allegro
Allegro…
This week, we chat with Evan Appleton, chief scientific officer and co-founder of Intertwined, a company focused on understanding mammalian evolved protective traits, and how they can be transferred to humans. And we chat with Lew Bender, CEO of Intensity Therapeutics, which is pioneering an intrat…
This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous system (CNS) cancers, and Shaun Holt, CEO of Alveo Technologies, about the potential for animal diseases to jump to humans, and what we can do about it.
Times:
03:27 Cerenome
2…
Times:
03:17 Asgard Therapeutics
32:43 Waiv
This week, we talk to a company in Lund, Asgard Therapeutics, and its co-founder and CEO Cristiana Pires, about in vivo direct cell reprogramming for cancer immunotherapy, and we chat about clinical diagnostics with Meriem Sefta, CEO of Waiv.
Asgard Thera…
This week, our guests are Bryan McClellan, who conducted research on pancreatic cancer as a postdoctoral fellow at Dell Medical School, and William Matsui, the study's senior author and former executive vice dean for research at Dell Medical School; and Theialife president and CEO, Thomas Ruggia, a…
This week, our guests are chief scientific officer of Valo Health, Karin Conde-Knape, and Karsten Eastman, CEO of Sethera Therapeutics.
Times:
03:06 Sethera Therapeutics
20:08 Valo Health
Valo Health
Our guest from Valo Health is chief scientific officer Karin Conde-Knape. As head of global drug di…
This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction capabilities. Our guests are John Schiel, program manager at ARPA-H; DNA Script co-founder and CTO, Xavier Godron; and John Nelso…
This week, we have a conversation Paweł Szczepański, CEO of JJP Biologics about specially-built antibodies to tackle autoimmune diseases and cancer.
JJP Biologics
JJP Biologics is a clinical-stage biotech that leverages its in-depth understanding of immune pathway science in autoimmune diseases and…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Jim Cornall, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
WYSZUKIWARKA PODCASTÓW
Możesz skorzystać z naszej strony internetowej, aby wyszukiwać podcasty3,825,439i odcinki195,922,192według osób, miejsc lub tematów.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki Base to Base Biotech.
ZGŁOŚ PRAWA DO TEGO PODCASTU
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post ogłoszenia drobne for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
wywiad z podcasterem...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
nasze oficjalne konto na X (dawniej Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
